Understanding the direct effects of melatonin on vertebrate ovulation remains a challenge. The present study provides the first characterization of the role of melatonin in ovulation using the teleost medaka. The melatonin receptor antagonist luzindole inhibited in vitro follicle ovulation. In the preovulatory follicles, arylalkylamine N-acetyltransferase 1a and hydroxyindole-Omethyltransferase 2, the enzymes responsible for melatonin synthesis, were expressed in the granulosa cells throughout the 24 h spawning cycle. The granulosa cells of the follicle also expressed the melatonin receptor 1a-a. An in vitro characterization study using medaka OLHNI-2 cells revealed that melatonin and luzindole act as an agonist and an antagonist, respectively, of the melatonin receptor. The intracellular cAMP levels in these cells were reduced after melatonin treatment. The expression of cytosolic phospholipase A2 group 4a (Pla2g4a), the enzyme producing arachidonic acid (cyclooxygenase-2 substrate), was inhibited in the granulosa cells in luzindole-treated follicles. Follicular prostaglandin E 2 levels and in vitro follicle ovulation were suppressed in follicles isolated at 12 h prior to ovulation and incubated with the Pla2g4a inhibitor AACOCF3. The G-actin:F-actin ratios in follicular cells increased with approaching ovulation, but this increase was suppressed after luzindole treatment. The phosphorylation of moesin, an ezrinradixin-moesin protein, was inhibited in the follicular cells in luzindole-treated follicles. These results indicate a dual role for melatonin in medaka ovulation: melatonin ensures prostaglandin E 2 synthesis throughout the spawning cycle and induces actin cytoskeleton rearrangement in the follicular cells at ovulation.
INTRODUCTION
Melatonin is a neurohormone primarily synthesized in and secreted from the pineal gland of vertebrates in a periodic manner, resulting in high blood levels at night and low levels during the day. Melatonin is produced from serotonin through the sequential actions of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT) [1, 2] , and daily variations of melatonin in the blood likely reflect the activity of AANAT [1] . The circadian production of melatonin in the pineal gland influences biological activities, including endocrine and non-endocrine rhythms [3] . The roles for melatonin in the central nervous system, hypothalamicpituitary-gonadal axis, cardiovascular system, immune system, and metabolism have been well documented in mammalian species [2, 3] . These effects are exerted through interactions with the G protein-coupled transmembrane melatonin receptors MT1 and MT2 [2, 4] . Melatonin also acts as an antioxidant to protect against free radical damage to macromolecules, cells, tissues, organs, and organisms [5, 6] . Consistently, melatonin synthesis occurs not only in the pineal gland but also in various organs throughout the body [7] . In addition, existing evidence indicates that melatonin modulates the actin cytoskeleton phenotype in neurons, epithelial cells, and cancer cells, suggesting the involvement of melatonin in cell migration and adhesion [8, 9] .
The association of melatonin with the regulation of reproductive functions in vertebrates has long been an intriguing subject. Previous studies using mammalian species have established a clear link between melatonin and reproduction [3, 10, 11] . In teleosts, accumulating evidence suggests that melatonin also affects reproduction [12] [13] [14] . These studies address a potential role for melatonin in the modulation of the hypothalamo-pituitary-gonadal axis in fish. In contrast, only a few reports have addressed the effect of melatonin on the reproductive organs of fish; in vitro oocyte maturation induced with 17a, 20b-dihydroxy-4-pregnen-3-one (17,20bP) , the naturally occurring steroid hormone, functioning as a maturation-inducing hormone (MIH) in many teleost fish [15] , was significantly accelerated after melatonin treatment in carp oocytes [16, 17] and zebrafish follicles [18] . However, there have been no studies exploring the direct effects of melatonin on ovarian function from a mechanistic point of view in any species.
The small freshwater teleost medaka (Oryzias latipes), which has a circadian cycle of oviposition, serves as a model for studying the reproduction of lower vertebrate animals [19] . In the past decade, our knowledge of the mechanism of ovulation, particularly the mechanism of follicular rupture, has been advanced after studying this fish [20] [21] [22] [23] [24] [25] [26] . Thus, the medaka might be the most beneficial animal model for investigating the effects of melatonin on ovulation. In the present study, we provided the first evidence that melatonin serves as a critical factor for fish ovulation.
MATERIALS AND METHODS

Medaka and Tissue Preparation
Adult Japanese medaka, O. latipes, was used. These fish were maintained and acclimated to artificial reproductive conditions (14L:10D, 268C) to establish a 24 h spawning cycle; the fish ovulated each day at the start of the light period, set to 0 h [20] . Medaka tissues, ovarian follicles, and follicular layers of the follicles were obtained as previously described [21] . The experimental procedures used in this study were approved through the Committee of the Center for Experimental Plants and Animals, Hokkaido University.
In Vitro Ovulation
Ovarian follicles isolated at various time points prior to ovulation were incubated with or without medaka recombinant Lh (rLh) in 90% medium 199 solution (pH 7.4) containing 50 lM gentamycin as previously described [21] . In some experiments, the incubation medium contained luzindole (Lz, a melatonin receptor antagonist, 10-100 lM) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), melatonin (10 lM) (Sigma-Aldrich, St. Louis, MO), serotonin (500 lM) (Sigma-Aldrich), CYP1A inhibitor (100 lM) (SigmaAldrich), GW627368X (an antagonist of prostaglandin E 2 [PGE 2 ] receptor, 10 lM) (Cayman Chemicals, Ann Arbor, MI), cytochalasin B (an actin cytoskeleton disruptor, 10 lM) (Sigma-Aldrich), jasplakinolide (an inhibitor of actin filament disassembly, 0.5 lg/ml) (Enzo Life Sciences, Farmingdale, NY), or AACOCF3 (an inhibitor of cytosolic phospholipase A 2 , 100 lM) (Enzo Life Sciences). After incubation at 268C for the duration indicated, the follicles were subjected to germinal vesicle breakdown (GVBD) and ovulation rate determination, real-time RT-PCR, Western blot analysis, melatonin and PGE 2 quantification, and other analyses.
Cloning
Among the medaka gene transcripts evaluated in the present study, the nucleotide sequences for hiomt2, pla2g4a, mtnr1c, and msna were incomplete or different from those currently available from the National Center for Biotechnology Information (NCBI) database. Therefore, these genes were subjected to cDNA cloning.
For hiomt2, the coding region was PCR amplified using a KOD FX Neo-DNA polymerase (Toyobo, Osaka, Japan) and medaka ovary cDNA. The primers used were 5 0 -SS for HIOMT2 and 3 0 -AS for HIOMT2 (Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). The amplified products were phosphorylated, gel-purified, ligated into the pBluescript II vector (Agilent Technologies, Santa Clara, CA), and sequenced.
For pla2g4a, the nucleotide sequences of the 5 0 and 3 0 unknown regions were determined using rapid amplification of 5 0 -cDNA ends (5 0 -RACE) and 3 0 -RACE methods, respectively. 5 0 -RACE was performed using the following protocol. Total RNA (2.5 lg) isolated from a medaka ovary at 3 h prior to ovulation was reverse-transcribed with the primer GSP-1 for pla2g4a using a SuperScript III Reverse Transcriptase (Life Technologies, Inc., Rockville, MD) according to the manufacturer's instructions. The synthesized cDNA was purified using a QIAquick PCR Purification Kit (Qiagen, Valencia, CA), and a homopolymeric tail was subsequently added to the 3 0 -end of the purified cDNA using recombinant terminal deoxynucleotidyl transferase (Life Technologies) with dCTP. PCR was conducted using the cDNA as a template and the TaKaRa Ex taq Hot Start Version (Takara Bio, Shiga, Japan). The primer pair used for pla2g4a was GSP-2 and a polyC anchor (Supplemental Table S1 ). The PCR conditions were 948C for 3 min, followed by 35 cycles at 948C for 0.5 min, 558C for 0.5 min, and 728C for 2 min. The resulting solution was diluted 100-fold in 10 mM Tris-HCl, pH 8.0, and 1 mM ethylenediaminetetraacetic acid buffer, and a subsequent PCR reaction was conducted using the diluted DNA as a template. The primer pair used for pla2g4a was GSP-3 and a nested anchor. The PCR conditions were the same as those used for the first PCR reaction. The amplified product was subcloned into a pBluescript II vector and sequenced. 3 0 -RACE was performed using a 3 0 -Full RACE Core Set (Takara) according to the manufacturer's instructions. The primers used for cPLA 2 and pla2g4a were 3 0 -RACE and 3 0 -RACE-2, respectively. The sequences of the primers used are listed in Supplemental Table S1 . To confirm the sequence of the full-length cDNA for pla2g4a, RT-PCR was conducted using KOD FX DNA polymerase with the ovary cDNA, and the nucleotide sequence of the products was confirmed through sequencing. The primers for cPLA 2 and pla2g4a were 5 0 -SS and 3 0 -AS, respectively (Supplemental Table S1 ). To obtain information for the nucleotide sequences of the 5 0 unknown regions of mtnr1c and msna, a basic local alignment search tool analysis was performed using the NCBI expressed sequence tag database, and information for the mtnr1c (accession number DK146774) and msna (DK013019) sequences were obtained. Primers were designed based on these sequences, RT-PCR was conducted using ovary cDNA, and the sequences of the fulllength cDNA for mtnr1c and msna were confirmed through sequencing.
Complementary DNA cloning for N-cadherin (cdh2) was performed in manner similar to that for pla2g4a as described above. The 5 0 and 3 0 unknown regions of the medaka cdh2 sequence were obtained using the 5 0 -RACE and 3 0 -RACE systems, and the full-length cdh2 cDNA sequence was determined. The primer sets used are listed in Supplemental Table S1 . The sequences determined were deposited into the DDBJ/GenBank/NCBI database (accession numbers
RT-PCR and Real-Time RT-PCR
RT-PCR analysis was performed as previously described with slight modifications [20] . Total RNA (2 lg) was reverse-transcribed with oligo-(dT) 20 primers, and the PCR reaction was conducted using the primers listed in Supplemental Table S1 . All PCR reactions were performed using the following cycle conditions: 948C for 3 min, followed by 30 cycles at 948C for 0.5 min, 608C for 0.5 min, and 728C for 0.5 min. Real-time PCR was conducted using a Thermal Cycler Dice Real Time System II (Takara) as previously described [21] . The sequences of the real-time PCR primers used are listed in Supplemental Table S1 . For detection of aanat1a, msna, and rdxb mRNA through real-time PCR, a KOD SYBR qPCR Mix (Toyobo) was used for the reaction. Real-time PCR was performed using the KAPA Fast qPCR Kit (Nippon Genetics Co., Ltd., Tokyo, Japan) to measure the mRNA levels of the other genes examined. The mRNA levels of the target genes were normalized to the cytoplasmic actin (actb) or translation elongation factor 1 alpha1 (eef1a) genes.
Isolation and Culture of Primary Granulosa Cells
Primary granulosa cells were isolated from preovulatory follicles obtained 3 h prior to ovulation as previously described [27] . After culturing in L-15 medium (Life Technologies) supplemented with 10% fetal bovine serum (Wako, Osaka, Japan), 13 penicillin-streptomycin-amphotericin B suspension (Wako), and 2 mM L-glutamine (Wako) at 268C for 48 h, the cells were harvested and subjected to various analyses.
Antibody Preparation
Antigens of Aanat1a, Hiomt2, Pla2g4a, Msn A, and Cdh2 were produced using an Escherichia coli expression system. Partial or complete coding regions of the genes were amplified with medaka ovary cDNA using KOD plus DNA polymerase. The primer pairs used are listed in Supplemental Table S1 . For Pla2g4a and Msn A, the amplified PCR products were phosphorylated, gelpurified, and ligated into a pET30a vector (Millipore, Billerica, MA) previously digested with EcoR V. For Aanat1a, Hiomt2, and Cdh2, the amplified products were digested with EcoR I and Xho I (for Aanat1a), EcoR I and Hind III (for Hiomt2), or Nde I and Xho I (for Cdh2), gel-purified, and ligated into a pET30a vector previously digested with EcoR I and Xho I (for Aanat1a), EcoR I and Hind III (for Hiomt2), or Nde I and Xho I (for Cdh2). The sequences of the resulting vectors were confirmed through DNA sequencing. The induction and purification of the recombinant proteins were performed as previously described [28] . The antibodies were produced using mice according to a previously described method [21] . Anti-medaka Mtnr1c antibody was generated for the synthetic peptide (CEQRTRLKPSD) conjugated to keyhole limpet hemocyanin using rabbits.
Commercially available antibodies were used for the detection of Mtnr1a-a, Msn A, Rdx B, a-tubulin, histone H3, and phospho-ERM. Rabbit polyclonal anti-MEL-1A-R (GTX100003; GeneTex, San Antonio, TX), rabbit polyclonal anti-Moesin (GTX101708; GeneTex), rabbit polyclonal anti-Radixin (GTX105408; GeneTex), rabbit anti-Phospho-Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558) (41A3) (CST3149; Cell Signaling Technology, Danvers, MA), mouse monoclonal anti-a-Tubulin antibody (T9026; Sigma), and mouse monoclonal Anti-Histone H3 antibody (MABI0001-20; MAB Institute Inc., Sapporo, Japan) were purchased and used. Anti-medaka Actb antibody was prepared as previously described [24] . All specific antibodies generated in the present study were purified using antigens blotted onto polyvinylidene difluoride membranes according to the previous method [21] and used for Western blotting at 100-200 dilution.
Because the present study primarily depended on the use of antibodies for Western blot and functional analyses, the specificity of the antibodies were carefully analyzed (Supplemental Fig. S1 ). The purity of the antigens that were purified using Ni-affinity chromatography were analyzed using SDS-PAGE followed by Coomassie Brilliant Blue staining. To examine the specificity of the antibodies, Western blot analysis was performed using the antigens and the follicle layer extract. As a negative control, either the primary antibody was preincubated with antigen (20 lg) for 16 h at 48C or the normal immunoglobulin G (IgG) fraction was used.
Immunoprecipitation
Ovarian follicles isolated from ovaries at 7 h prior to ovulation were sonicated in buffer A (50 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 1% Triton X-OGIWARA AND TAKAHASHI 100, and 0.1% SDS) containing 13 protease inhibitor cocktail (Wako) and 13 phosphatase inhibitor cocktail (Wako) and incubated at 48C for 4 h. The lysates were subsequently centrifuged at 13 000 3 g for 10 min, and the resulting supernatant was used for immunoprecipitation. Protein G-Sepharose beads (Life Technologies) were incubated in 20 mM Tris-HCl, pH 8.0, containing 0.15 M NaCl and 0.05% Tween-20 with a purified anti-Msn A antibody or a normal mouse IgG (Sigma) for 2 h at 48C. The beads were subsequently washed with buffer A and incubated in buffer A with the extracts at 48C for 16 h. The beads were washed with buffer A four times, followed by washing with 50 mM Tris-HCl, pH 8.0, incubation with SDS sample buffer containing 2-mercaptoethanol for 20 min at 958C, and Western blot analysis using antiphosphor-ERM and anti-Msn A antibodies.
Western Blot Analysis
Follicular layers and the follicular layer-derived granulosa cells were incubated in 50 mM Tris-HCl (pH 8.0), containing 1% SDS at 958C for 15 min, followed by centrifugation at 13 000 3 g for 10 min. The resulting supernatants were used for Western blot analysis. The protein concentrations were determined using a bicinchoninic acid kit (Thermo Fisher Scientific, Waltham, MA). Western blot analysis was performed as previously described with slight modifications [21] . Briefly, the proteins were separated through SDS-PAGE and subsequently transferred to polyvinylidene difluoride membranes. The membranes were blocked with 2% Block Ace (Dainippon-Sumitomo Seiyaku Co., Osaka, Japan) containing 0.02% NaN 3 at room temperature for 1 h and subsequently incubated with a primary antibody in TPBS (PBS containing 0.2% Tween-20) (for Hiomt2, Mtnr1a-a, Msn A, Histone H3, Tubulin, Cdh2, and Actb) or IMMUNO SHOT Reagent 1 (Cosmo Bio Co., Ltd., Tokyo, Japan) (for Aanat1a and Pla2g4a). After washing four times with TPBS, the membranes were incubated with a secondary antibody diluted with TPBS (for Hiomt2, Mtnr1a-a, Msn A, Histone H3, Tubulin, Cdh2, and Actb) or IMMUNO SHOT Reagent 2 (Cosmo Bio) (for Aanat1a and Pla2g4a) at 1:5000. For the detection of pERM, the membranes with transferred proteins were blocked in TTBS (20 mM Tris-HCl, pH 7.5, 0.2 M NaCl, and 0.2% Tween 20) containing 1% bovine serum albumin at room temperature for 1 h. Incubations with primary and secondary antibodies and washing were performed in TTBS. For the detection of Msn A in the immunoprecipitated materials, the membranes were blocked with TTBS containing 1% bovine serum albumin and subsequently reacted with rabbit polyclonal anti-Moesin (GeneTex), or rabbit anti-Phospho-Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558) (41A3) (Cell Signaling Technology) antibodies in TTBS for 1 h. After washing with TTBS, the membranes were incubated with an ImmunoCruz IP/WB Optima F System Western blot detection reagent (Santa Cruz Biotechnology) diluted in IP/WB Optima E Dilution Reagent (Santa Cruz Biotechnology) at 1:1000. The signals were detected using an Immobilon Western kit (Millipore, Bedford, MA) according to the manufacturer's instructions.
Fractionation
Follicular layers obtained at 3 h prior to ovulation were fractionated into nuclear, membrane, and cytosolic fractions using a ProteoExtract Subcellular Proteome Extraction kit (Calbiochem-EMD Millipore Corp., Billerica, MA) according to the manufacturer's instructions. The fractions were boiled in SDS sample buffer and subjected to Western blot analysis.
Extraction and Quantitative Measurement of Melatonin
Medaka ovarian follicles were homogenized in PBS containing 1% SDS and subsequently incubated at 48C for 1 h. The samples were centrifuged at 12 000 3 g for 10 min, and the resulting supernatants were collected. Medaka blood serum was prepared as previously described [29] . The protein concentrations of the supernatants or the sera were determined using a bicinchoninic acid kit. Melatonin in the supernatants or sera was extracted with two volumes of chloroform. After centrifugation at 12 000 3 g for 5 min, the organic phase was collected and dried through evaporation. The resulting precipitate was dissolved in 100% methanol and used for melatonin measurement using a Melatonin ELISA Kit (RE54021; IBL International, Hamburg, Germany). For this measurement kit, the analytical sensitivity (limit of detection) is 1.6 pg/ml; the standard range is 3.0-350 pg/ml; the analytical specificity (cross reactivity) for 5-methoxy-tryptophole, N-acetyl-serotonin, and 5-methoxy-tryptamine is 1.2%, 1.2%, and 2.5%, respectively; the cross reactivity of other substrates tested is ,0.01%; and the mean of recovery after spiking is 102.4%.
Measurement of the cAMP Levels in Live Cells Transiently Expressing Mtnr1a-a
The coding region of Mtnr1a-a was amplified with ovary cDNA using a KOD-Plus-Neo-DNA polymerase (Toyobo). The primer pair used was MTNR1a-a pCMV SS and MTNR1a-a pCMV AS (Supplemental Table S1 ). The amplified product was digested with EcoR I and Xho I, gel-purified, and ligated into a pCMV tag 4 vector (Agilent Technologies) previously digested with the same enzymes. The sequence of the resulting vector, pCMV-Mtnr1a-a, was confirmed through DNA sequencing. OLHNI-2 cells (Riken cell bank, Tukuba, Japan), a medaka fin-derived cell line, were cultured at 338C in L-15 (Life Technologies) supplemented with 10% fetal bovine serum (Wako), 10 mM HEPES (Life Technologies), 13 penicillin-streptomycin-amphotericin B suspension (Wako), and 2 mM L-glutamine (Wako). The cells were transfected with pCMV-Mtnr1a-a and pGloSensor-22F cAMP Plasmid (Promega, Madison, WI) using ScreenFect A (Wako) according to the manufacturer's instructions. After incubation for 48 h, the medium was changed into fresh medium containing 1% Glosensor cAMP reagent (Promega), and the cells were incubated for 2 h at room temperature with gentle shaking. The cells were subsequently harvested and resuspended in PBS containing 1 lM forskolin (FSK) (Sigma) at 1 3 10 6 cells/ml. The luciferase activity in the cells was monitored every minute using a luminometer. After 5 min, melatonin (100 nM) (Sigma) was added to the suspension, and the activity was assessed every minute for 20 min.
Detection of G/F-Actin
The G-actin:F-actin ratio was measured as previously described with slight modifications [30] . Follicular layer cells from preovulatory follicles and OLHNI-2 cells previously transfected with the pCMV-Mtnr1a-a vector were used. The cells were gently homogenized in actin stabilization buffer (0.1 M PIPES, pH 6.9, 30% glycerol, 5% dimethyl sulfoxide [DMSO], 1 mM MgSO 4 , 1 mM ethylene glycol tetraacetic acid, 1% Triton X-100, 1 mM ATP, and 13protease inhibitor cocktail [Wako] ) and incubated on ice for 10 min. The cells were subsequently centrifuged at 16 000 3 g for 75 min at 48C. The resulting supernatant containing G-actin was collected, and the precipitate containing F-actin was boiled in 50 mM Tris-HCl, pH 8.0, containing 1% SDS for 10 min. After boiling, the samples were centrifuged at 13 000 3 g for 10 min, and the resulting supernatants recovered. The supernatant samples and precipitate fractions were subjected to 10% SDS-PAGE/Western blots. The actin bands were detected using an anti-medaka Actb antibody. The optical band density was measured with CS Analyzer 2.0 Software (ATTO, Tokyo, Japan).
Measurement of PGE 2 in Follicles Incubated In Vitro
Follicles incubated in vitro (25-30 follicles per sample) were collected and used for measurement of the PGE 2 levels. The extract preparations and PGE 2 determination were performed as previously described [22] .
Statistical Analysis
All values are presented as the means 6 SEM of independent experiments. The number of experiments performed is indicated in the figure legends. Statistical significance was verified using Student t-test (two groups were compared with equal variances using an F-test) and one-way ANOVA, followed by Dunnett test as the post hoc test (greater than two groups were compared with equal variances using a Bartlett test) or a Kruskal-Wallis test (greater than two groups with unequal variances), as appropriate. Analyses were performed using Excel software. In the present study, P-values less than 0.05 (*) or 0.01 (**) were considered statistically significant.
RESULTS
Lz Inhibits In Vitro Ovulation in Medaka
The effects of the melatonin receptor antagonist Lz on ovulation were examined in vitro using preovulatory follicles isolated at 12 h prior to ovulation (Fig. 1A) . Lz inhibited ovulation at concentrations of 20 to 100 lM (Fig. 1B) . The inhibition of ovulation through Lz was rescued after the addition of 10 lM melatonin. Next, the follicles were isolated at 12, 8, 4, 2, or 0 h prior to ovulation and incubated with Lz under various conditions (Fig. 1C) . A strong inhibitory effect MELATONIN IN MEDAKA OVULATION of Lz on ovulation was observed, even when the follicles isolated at 4 or 2 h prior to ovulation were exposed to the antagonist for 2-4 h. Incubation of the follicles isolated at 12 h prior to ovulation with Lz for 8 h also significantly suppressed ovulation. Oocyte maturation remained unaffected after Lz treatment of the follicles (Fig. 1D) . Furthermore, the oocytes of the follicles that had been treated with Lz (100 lM) for 16 h were mechanically obtained by removing the follicle layers with forceps and subjected to in vitro fertilization [31] . After fertilization, fertilized oocytes developed into blastocysts at high rates (more than 70%), indicating that Lz is not toxic even at the 100 lM concentration. These results suggest the involvement of melatonin in the ovulation in the medaka ovary.
Preovulatory Follicles Produce Melatonin at a Constant Level During the 24 h Spawning Cycle
We examined the expression the genes/proteins responsible for melatonin production in the preovulatory follicles of the medaka ovary, including arylalkylamine N-acetyltransferase (gene name, aanat; protein name, Aanat in medaka) and hydroxyindole-O-methyltransferase (hiomt and Hiomt, respectively). A search of the NCBI (http://www.ncbi.nlm.nih.gov/)
[32] or Ensembl genome databases (http://www.ensembl.org/ index.html) [33] indicated that medaka possesses two aanat genes (aanat1a and aanat1b) and three hiomt genes (hiomt1, hiomt2, and hiomt3). A preliminary analysis was conducted using RT-PCR (on various tissues) (Supplemental Fig. S2A ) and real-time RT-PCR (for ovary and brain) (Supplemental Fig. S2C , left and middle panel) to detect the expression of these genes. The aanat1a and hiomt2 genes were expressed in the medaka ovary. The expression levels of aanat1a mRNA in the fish preovulatory follicles were significantly higher at 3 and 5 h prior to ovulation during the 24 h spawning cycle, whereas the levels of hiomt2 mRNA remained fairly constant ( Fig. 2A) . The expression of Aanat1a and Hiomt2 proteins were detected through Western blot analysis using extracts from layers of the preovulatory follicles at invariable levels during the last half of the spawning cycle (Fig. 2B) . Extracts of oocytes separated from preovulatory follicles 3 h before ovulation showed no protein bands corresponding to Aanat1a or Hiomt2 in a Western blot (Fig. 2C) , suggesting that the cells of the follicle layer mainly play a role in melatonin production in preovulatory follicles. Therefore, we conducted further experiments using follicle cells but not oocytes. Follicles isolated at 12 h prior to ovulation were incubated with either DMSO or Lz. Follicles cultured without additives were also used as a control. The rates of GVBD were determined (n ¼ 5).
OGIWARA AND TAKAHASHI FIG. 2. Expression of melatonin-synthesizing enzymes in the medaka ovary. A) Transcript levels of aanan1a (left) and hiomt2 (right) were examined through real-time RT-PCR analysis using preovulatory follicles during the 24 h spawning cycle. Total RNA was extracted from the follicles isolated at the indicated time points. The expression levels were normalized to those of eef1a (for aanan1a) or actb (for hiomt2) and expressed as the fold-change compared with the levels of the À23 h follicles. Asterisks indicate a significant difference at P , 0.01 (**) compared with the expression of the À23 h follicles (one-way ANOVA, post hoc Dunnett test). The results are presented as the means 6 SEM (n ¼ 5). B) Western blots for Aanat1a (left) and Hiomt2 (right) was conducted with the extracts of the follicular layers of preovulatory follicles isolated from spawning fish ovaries. Antibodies against recombinant medaka Aanat1a and Hiomt2 were used. For the analysis of Aanat1a, the antibody was preincubated with antigen and subsequently used in the À3 h follicle layer extract (Abs). Note that the antigen band (24 kDa) disappeared when antibodies that were previously treated with the antigen were used, indicating that the 24-kDa band is medaka Aanat1a. The positions of various molecular masses are indicated. The dotted line panel represents the cropping of a single gel. A single band (67 kDa) was detected with the Hiomt2 antibody. Actb was used as a control. The positions of various molecular masses are indicated. The dotted line represents cropping of a single gel. The reproducibility of the results was confirmed after repeating at least three times, and the results of one experiment are presented. C) Western blot analysis for Aanat1a and Hiomt2 was conducted with the extracts of the follicular layers and the oocytes that were separated from preovulatory follicles that were isolated from spawning fish ovaries 3 h prior to ovulation. Aliquots of the extracts (20 lg for Aanat1a and 10 lg for Hiomt2) were applied. Actb was used as a control. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. D) RT-PCR analysis of mRNAs for melatonin-synthesizing enzymes (aanan1a and
MELATONIN IN MEDAKA OVULATION
RT-PCR analysis was conducted using total RNAs isolated from the follicle layer and follicle layer-derived granulosa cells. Amplified products for aanat1a and hiomt2 were detected in both fractions (Fig. 2D ). Western blots with the extracts of the granulosa cell fraction revealed the expression of the Aanat1a and Hiomt2 proteins (Fig. 2E) . These results indicate that Aanat1 and Hiomt2 are expressed in the granulosa cells of preovulatory follicles destined for ovulation.
Changes in the melatonin levels of sera and preovulatory follicles were determined every 2 h during the spawning cycle. In sera, the melatonin levels were low during the first half of the cycle, but were elevated in the last half of the cycle ( Fig  3A, upper panel) . The circulating daytime and nighttime melatonin levels in the medaka serum were both slightly lower (50-100 ng/ml during the daytime and 150-500 ng/ml during the nighttime) than those reported for other teleost species [34] . In contrast, no detectable change was observed in the follicular levels of melatonin during the spawning cycle (Fig. 3A, lower  panel) . To examine whether melatonin was secreted from follicles into the incubation medium, follicles isolated at 12 h prior to ovulation were cultured in vitro for 12 h, and the melatonin levels were measured using culture media. The levels were too low to detect, indicating that melatonin is not secreted from the follicles at detectable levels under these conditions. Next, melatonin production in the preovulatory follicle was examined. When these follicles were incubated with serotonin, the physiological substrate of Aanat, the melatonin levels in the follicle were significantly increased (Fig. 3B) . The follicular melatonin levels increased with the addition of an inhibitor of cytochrome P-450 1A (CYP1A) in the culture, the physiological enzyme for melatonin degradation. The expression of cytochrome P-450 1A mRNA in the granulosa cells of the preovulatory follicle was also demonstrated (Fig. 2D) .
Taken together, these results demonstrated that melatonin is constitutively synthesized in the granulosa cells of preovulatory follicles during the 24 h medaka spawning cycle. These results also indicate that the follicles possess enzymatic systems capable for generating and degrading melatonin to maintain constant follicular levels during spawning.
The Melatonin Receptor 1a-a Is Expressed in the Granulosa Cells of Preovulatory Follicles
Medaka contains four subtypes of the melatonin receptor, Mtnr1a 1.4, Mtnr1a 1.7 (also known as MT1/Mel1a), Mtnr1b (also known as MT2/Mel1b), and Mtnr1c (also known as Mel1c) [32] . In the present study, the names of the mtnr genes were mtrn1a-b (corresponding to mtnr1a 1.4), mtrn1a-a (corresponding to mtnr1a 1.7), mtnr1b, and mtnr1c. The transcripts for these receptor genes were detected through PCR (Supplemental Fig. S2B ) and real-time RT-PCR (Supplemental Fig. S2C , right panel) using total RNAs isolated from various tissues of the fish. The mtnr1a-a and mtnr1c genes were expressed in the ovary. The expression of mtnr1c mRNA was approximately 8.5 times greater than that of mtnr1a-a mRNA in the follicular layer of the preovulatory follicle 3 h prior to ovulation (Supplemental Fig. S2D ). However, Western blot analysis using specific antibodies detected Mtnr1a-a protein, but not Mtnr1c protein, in ovary extracts (Supplemental Fig.  S2E ), demonstrating that the fish ovary exclusively expresses Mtrn1a-a protein. The transcript levels of mtrn1a-a did not fluctuate during the 24 h spawning cycle (Fig. 4A) . Consistent with this observation, Mtnr1a-a protein was detected at a 3 hiomt2) and cytochrome P-450 1A (cyp1a1) was conducted using total RNAs isolated from the follicular layer and granulosa cells 3 h prior to ovulation. The expression of marker genes was also analyzed: mmp16 for the oocyte, mmp9 for granulosa cells, and col4al for theca cells. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. E) Western blot analysis of melatonin-synthesizing enzymes was conducted using specific anti-medaka Aanat1a or Hiomt2 antibodies with extracts from isolated granulosa cells. Actb was used as a control. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. Preovulatory follicles isolated at 12 h prior to ovulation were cultured in vitro with either serotonin or CYP1A inhibitor. After 12 h of incubation, the melatonin levels in the follicles were measured. Follicles cultured without additives were used as a control. Asterisks indicate a significant difference at P , 0.05 (*) or P , 0.01 (**) compared with the control (ttest, n ¼ 6).
OGIWARA AND TAKAHASHI constant level in the follicular layer extracts of preovulatory follicles predicted to ovulate in 11 h (Fig. 4B) . Both mtnr1a-a mRNA and protein were associated with the granulosa cells of the preovulatory follicles (Fig. 4, C and D) . Furthermore, Mtnr1a-a was localized to the membrane fraction of the follicular layers of the preovulatory follicles (Fig. 4E) .
The responsiveness of medaka Mtnr1a-a to melatonin and Lz was examined using OLHNI-2 cells, a cell line established using cells isolated from the medaka fin. These cells expressed both Mtnr1a-a and luciferase fused with a cAMP-binding domain. Treatment of OLHNI-2 cells with FSK induced a steady increase in luciferase activity in response to increased intracellular cAMP concentrations for up to 9 min after treatment (Fig. 4F) . When melatonin was added to the culture at 5 min after the start of FSK treatment, the luciferase activity immediately decreased. After the addition of both melatonin and Lz at 5 min, the decrease in luciferase activity induced through melatonin alone was negated to a considerable extent. These results indicate that melatonin and Lz are an agonist and antagonist, respectively, of medaka Mtnr1a-a and agonist binding to the receptor decreases the intracellular cAMP concentration.
FIG. 4.
Expression of the melatonin receptor 1a-a in the preovulatory follicle of the medaka ovary. A) Transcript levels of mtnr1a-a were examined through real-time RT-PCR analysis using preovulatory follicles during the 24 h spawning cycle. Total RNAs were extracted from the follicles isolated at the indicated time points. The expression levels were normalized to those of actb and expressed as a fold-change compared with the levels of the À23 h follicles. The results are presented as the means 6 SEM (n ¼ 5). B) Mtnr1a-a expression was analyzed through Western blots using the extracts of follicle layers of preovulatory follicles isolated from medaka ovaries. Antibodies raised for recombinant medaka Mtnr1a-a were used. As a negative control, normal rabbit IgG was employed. Note that the antigen band (26 kDa) disappeared regardless of whether the normal IgG was used, indicating that the 26-kDa band is medaka Mtnr1a-a. The positions of various molecular masses are indicated. The dotted line in the left panel represents the cropping of a single gel. The reproducibility of the results was confirmed after repeating at least three times, and the results of one experiment are presented. C) RT-PCR analysis of mRNA for mtnr1a-a was conducted using total RNAs isolated from the follicular layer and granulosa cells 3 h prior to ovulation. The expression of marker genes was analyzed as in Figure 2D . The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. D) Western blot analysis for Mtnr1a-a was conducted using a specific anti-medaka Mtnr1a-a antibody with the extract from follicular layers or granulosa cells isolated from the À3 h follicles. Actb was used as a control. Dotted lines indicate cropped images from separate blots, and all samples were run under the same experimental conditions. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. E) Western blot analysis for Mtnr1a-a was conducted with the extracts of various intracellular fractions prepared from the follicular layers of the À3 h follicles. The marker proteins used were N-cadherin for the membrane, histone H3 for the nucleus, and tubulin for the cytosolic fraction. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. F) OLHNI-2 cells transfected with pCMV-Mtnr1a-a and pGloSensor-22F cAMP plasmids were stimulated with 1 lM forskolin (Fsk) for 5 min, followed by the addition of 100 nM melatonin (Mtn) with or without 50 lM Lz. Luciferase activity was measured every 1 min. The activity at 5 min after the measurement was set to an arbitrary value of 1, and the relative activity was expressed as the fold-change compared with the activity at 5 min. Activity was significantly reduced after melatonin addition at all points from 6 to 15 min, as indicated with asterisks at P , 0.01 (**) compared with the activity at 5 min (one-way ANOVA, post hoc Dunnett test, n ¼ 5).
MELATONIN IN MEDAKA OVULATION
Treatment of Preovulatory Follicles with Lz Dramatically Reduces the Expression of Cytosolic Pla2g4a
The effect of Lz on the expression of various genes in the preovulatory follicles was examined. Particularly, the genes implicated in medaka ovulation were examined [20] [21] [22] [23] [24] [25] [26] . Among these genes, the expression levels of cytosolic phospholipase A2 group 4a (pla2g4a and Pla2g4a), which hydrolyzes membrane phospholipids to release arachidonic acid, the substrate of cyclooxygenase-2 (ptgs2 and Ptgs2) [35] , were dramatically reduced after treatment (Fig. 5A) . The follicular expression of pla2g4a remained constant during the spawning cycle (Fig. 5B) . Western blot analysis revealed Pla2g4a protein expression in the follicle layer of the follicles at a constant level in the last half of the spawning cycle (Fig.  5C) . However, the Pla2g4a levels were significantly decreased in the follicles after incubation with Lz (Fig. 5D) . The inhibitory effect on follicular Pla2g4a expression was apparent at 6 h after incubation with Lz.
Because Lz suppressed the expression of Pla2g4a/pla2g4a in the preovulatory follicles, we next examined whether Lz treatment might affect PGE 2 synthesis by this enzyme. The PGE 2 levels were significantly reduced in follicles isolated at 12 h prior to ovulation, followed by incubation for 12 h with either Lz or AACOCF3 (an inhibitor for Pla2g4a enzyme) (Fig.  6A) . No inhibitory effects of Lz and AACOCF3 on PGE 2 FIG. 5. Effect of luzindole (Lz) treatment on the expression of Pla2g4a in the preovulatory follicle. A) Preovulatory follicles isolated at 12 h prior to ovulation were incubated with or without 50 lM Lz. After incubation for 12 h, total RNA was extracted from the follicles for real-time RT-PCR analysis. The expression levels for each gene were expressed as the fold-change compared with the levels of the follicles incubated without Lz (control) The foldchange for pla2g4a was compared with that for other genes (one-way ANOVA, post hoc Dunnett test, n ¼ 4). An asterisk indicates a significant difference at P , 0.01 (**). B) The transcript levels of pla2g4a were examined through real-time RT-PCR analysis using preovulatory follicles during the 24 h spawning cycle. Total RNAs were extracted from the follicles isolated at the indicated time points. The expression levels were normalized to those of actb and expressed as the fold-change compared with the levels of the À23 h follicles. The results are presented as the means 6 SEM (n ¼ 5). C) Western blot analysis for Pla2g4a was conducted with the extracts of follicular layers of the preovulatory follicles that were isolated from spawning fish ovaries. Actb was used as a control. Positions of various molecular masses and Pla2g4a are indicated. The dotted line represents the cropping of a single gel. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. D) Preovulatory follicles isolated at 12 h prior to ovulation were incubated with (right) or without Lz (left). The follicular layers of the follicles were collected every 3 h, and Western blot analysis was conducted for Pla2g4a using extracts prepared from the layers (upper panel). Actb was used as a control. The signal intensity of the Pla2g4a band was quantified densitometrically, and the ratio of expression of Pla2g4a to Actb was determined to present the relative expression (lower panel). The samples derived from the same experiment and blots were processed in parallel. An asterisk indicates a significant difference at P , 0.05 (*) compared with the intensity at 0 h (one-way ANOVA, post hoc Dunnett test, n ¼ 3). Positions of various molecular masses are indicated. The dotted line represents the cropping of a single gel.
OGIWARA AND TAKAHASHI production were observed in follicles isolated at 4 h prior to ovulation. In vitro follicle ovulation was completely inhibited in follicles isolated at 12 h prior to ovulation (Fig. 6B) . Moreover, AACOF3 was no longer effective on follicle ovulation in follicles isolated at 4 h prior to ovulation. These results indicate that AACOCF3 treatment of preovulatory follicles inhibits the expression of Pla2g4a/pla2g4a, leading to a decrease in PGE 2 synthesis in the follicle and eventually the inhibition of in vitro ovulation. RT-PCR analysis was conducted using total RNAs prepared from the granulosa cells of preovulatory follicles to evaluate pla2g4a, the genes involved in PGE 2 synthesis, the PGE 2 receptor cyclooxygenase-2 (ptgs2), PGE 2 synthase (ptges), and PGE 2 receptor subtype EP4b (ptger4b). PCR-amplified products were obtained for all four genes (Fig. 6C) , indicating that granulosa cells express pla2g4a, ptges, ptgs2, and ptger4b mRNAs.
Melatonin Appropriately Modulates the Polymerization of Actin Filaments in the Follicular Cells of Preovulatory Follicles as Ovulation Approaches
The present result that in vitro ovulation was effectively inhibited after exposing the follicles to Lz for several hours prior to ovulation suggests that melatonin might be involved in process(es) occurring in the follicular cells with impending ovulation. We hypothesized that melatonin might be involved in changes in follicle cell shape and migration during ovulation. Experiments were conducted to evaluate this hypothesis. To this end, we first examined whether the status of actin cytoskeleton polymerization in the follicular cells of the follicles would change with approaching follicle ovulation. The proportion of G-actin to F-actin increased 3.5-fold with time in the cells of untreated follicles (Fig. 7A) , indicating that follicle ovulation was accompanied by actin depolymerization in follicle cells. The G-actin:F-actin ratio in the follicular cells remained low following Lz treatment (Fig. 7B) . Compared with untreated follicles that successfully ovulated, jasplakinolide (an inhibitor of actin filament disassembly) reduced the Gactin:F-actin ratio, whereas cytochalasin B (an actin cytoskeleton disruptor) dramatically increased this ratio. Similarly, follicles treated with GW627368X (a PGE 2 receptor subtype Ptger4 antagonist) maintained low G-actin:F-actin ratios. Jasplakinolide (0.5 lg/ml), cytochalasin B (10 lM), and GW627368X (10 lM) [22] completely inhibited follicle ovulation (Fig. 7C) .
OLHNI-2 cells previously transfected with the pCMVMtnr1a-a vector were treated with melatonin to examine the effects of this protein on changes in the actin cytoskeleton. Melatonin treatment increased the G-actin:F-actin ratio (Fig.  7D) , indicating that intracellular actin cytoskeleton arrangement induced through the activation of the melatonin/Mtnr1a-a system might be a general phenomenon in this fish.
Because follicle ovulation is accompanied by actin cytoskeleton rearrangement in follicle cells, several genes/ proteins that play a role in actin cytoskeleton arrangement were examined. The results of the preliminary experiments indicated that Lz treatment of the preovulatory follicles inhibited the phosphorylation of Erm (ezrin-radixin-moesin) proteins in the follicles. Therefore, we further examined in detail the effect of Lz on the phosphorylation of Erm proteins. Among the six medaka Erm genes registered in the NCBI database (ezra, ezrb, rdxa, rdxb, msna, and msnb), transcripts for rdxb and msna were detected in the follicular layers of preovulatory follicles, but only msna mRNA was detected in granulosa cells isolated from the follicles (Fig. 8, A and B) . The msna mRNA expression levels were elevated in vivo in the preovulatory follicles with impending ovulation (Fig. 8C) . When the follicles that had not yet undergone an Lh surge were incubated, a marked increase in msna mRNA expression was observed, regardless of whether recombinant Lh was added to the culture (Fig. 8D) , indicating that the expression of the msna gene in preovulatory follicles was Lh independent. Consistent with the above results, Msn A protein, but not Rdx B protein, was detectable in the follicular layers at 7 h prior to ovulation, and these levels were maintained thereafter in the follicular layers (Fig. 9A) . A phosphorylated form of Erm was also detected in a pattern similar to that of Msn A through Western blot analysis. To examine whether the 67- kDa   FIG. 6 . Effects of Lz and AACOCF3 treatment on prostaglandin E 2 (PGE 2 ) synthesis and ovulation in the preovulatory follicle. A) Preovulatory follicles isolated at 12 or 4 h prior to ovulation were incubated with either 50 lM Lz or 100 lM AACOCF3. Follicles incubated without additives were also used as a control. After incubation for 12 (for follicles at 12 h prior to ovulation) (black bars) or 4 h (for follicles at 4 h prior to ovulation) (grey bars), the PGE 2 levels in the collected follicles were determined. Asterisks indicate a significant difference at P , 0.05 (*) (t-test, n ¼ 5). B) Follicles isolated at 12 (upper) or 4 h (lower) prior to ovulation were incubated with either DMSO or 100 lM AACOCF3. Follicles cultured without additives were also used as a control. The rates of ovulation were determined. Asterisks indicate a significant difference at P , 0.01 (**) (t-test, n ¼ 5). C) RT-PCR analysis of the mRNAs for pla2g4a, ptges, ptgs2, and ptger4b was conducted using total RNAs isolated from the follicular layer and granulosa cells 3 h prior to ovulation. The expression of marker genes was analyzed as in Figure 2D . The dotted line represents the cropping of a single gel. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented.
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FIG. 7. Effect of Lz treatment on the G-actin:F-actin ratio in the granulosa cells of the preovulatory follicle. A) Preovulatory follicles isolated at 4 h prior to ovulation were incubated in vitro. The follicular layers of the follicles were collected every 1 h and subjected to Western blot analysis to detect G-and F-actin (upper panel). The signal intensities of the bands were densitometrically quantified to determine the G-actin:F-actin ratio. The samples derived from the same experiment and blots were processed in parallel. Positions of various molecular masses are indicated. The dotted line represents the cropping of a single gel. Asterisks indicate a significant difference at P , 0.05 (*) or P , 0.01 (**) compared with the ratio at 0 h (one-way ANOVA, post hoc Dunnett test, n ¼ 3). B) Preovulatory follicles isolated at 4 h prior to ovulation were incubated in vitro with 50 lM Lz, 10 lM GW627368X (GW), 0.5 lg/ml of jasplakinolide (Jas), or 10 lM cytochalasin B (CB). Follicles cultured without additives (0 h and 4 h) were also used as controls. After incubation OGIWARA AND TAKAHASHI Erm protein recognized by anti-pErm antibody represents a phosphorylated form of Msn A, further experiments were conducted. The anti-pErm antibody detected a specific band in the materials that was precipitated using anti-Msn A antibody (Fig. 9B) , identifying the phosphorylated Erm protein (pErm) as phosphorylated Msn A protein (pMsn A). Msn A phosphorylation was inhibited after treatment with Lz, but not with jasplakinolide, cytochalasin B, or GW627368X (Fig.  9C) , suggesting that the activation of the melatonin/melatonin receptor system is closely associated with Msn A phosphorylation in ovulating follicles. As revealed by Western blot analysis, only the F-actin fraction contained phosphorylated Msn A (Fig. 9D) . The inhibition of Msn A phosphorylation through Lz treatment occurred within 3 h of incubation (Fig.  9E) . Thus, these results strongly suggested that in follicle rupture during ovulation, actin cytoskeleton rearrangement involving phosphorylated Msn A protein occurs in the follicular cells of periovulatory follicles and that this process is inhibited through the prevention of Msn A phosphorylation after treatment with the melatonin receptor antagonist Lz.
3 for 4 h, G-and F-actin in the follicular layers of the follicles were detected, and the G-actin:F-actin ratio was determined as in A. Asterisks indicate a significant difference at P , 0.01 (**) (t-test, n ¼ 5). Dotted lines indicate cropped images from separate blots, and the samples were run under the same experimental conditions. C) Follicles isolated at 4 h prior to ovulation were incubated with Jas (0.5 lg/ml), CB (10 lM), or GW (10 lM). Follicles cultured without additives were also used as a control. The rates of ovulation were determined. Asterisks indicate a significant difference at P , 0.01 (**) compared with the ovulation rate of the control (t-test, n ¼ 5). D) OLHNI-2 cells transfected with the pCMV-Mtnr1a-a vector were treated for 24 h with or without 100 nM melatonin. G-actin and F-actin in the treated and untreated cells were then detected by Western blot analysis using an anti-medaka Actb antibody. The signal intensities of the bands were densitometrically quantified to determine the G-actin:F-actin ratio. The samples derived from the same experiment and blots were processed in parallel. The results are presented as the means 6 SEM (n ¼ 3). An asterisk indicates a significant difference at P , 0.05 (*) (t-test).
FIG. 8. Expression of Mesin
A mRNA in the ovary. A) RT-PCR analysis for mRNA expression of Erm genes (msna, msnb, rdxa, rdxb, ezra, and ezrb) was conducted for preovulatory follicles isolated at 3 h prior to ovulation. The follicular layers of the follicles and the granulosa cells were used to prepare total RNA. The expression of marker genes was also analyzed as in Figure 2D . The reproducibility was confirmed after repeating the experiments three times, and the results of one experiment are presented. B) The levels of msna and rdxb mRNA expression were examined through real-time RT-PCR analysis using total RNA prepared from follicular layers of preovulatory follicles isolated 3 h prior to ovulation. The expression levels were normalized to those of eef1a. The results are presented as the means 6 SEM (n ¼ 5). C) The levels of msna mRNA expression were examined through real-time RT-PCR analysis using follicles that were destined to ovulate within 48 h. Total RNAs were extracted from the follicles isolated at the indicated time points. The expression levels were normalized to those of eef1a and expressed as the fold-change compared with the levels of the À47 h follicles. The results are presented as the means
DISCUSSION
Sexually mature female medaka undergo a 24 h spawning cycle, and this periodic reproductive activity is principally controlled through a surge of Lh. Recent studies have revealed that successful ovulation requires the synchronized activities of a variety of proteins, including proteolytic enzymes and PGE 2 receptors [36] . Some of these proteins are Lh-inducible and play a critical role in this process. In previous studies to identify additional factors involved in fish ovulation, we observed that the melatonin receptor antagonist Lz was a potent inhibitor of in vitro ovulation in medaka preovulatory follicles. In the present study, the effects of Lz on the follicle ovulation were examined at 20-100 lM, a concentration range 1-to 2-fold higher than that generally used for these studies [37] . However, the follicles incubated with Lz, even at a concentration as high as 100 lM for 16 h, were viable, and more importantly, the inhibitory effect of Lz on ovulation was inhibited after the addition of melatonin to the incubation medium. These considerations indicate that the concentrations of Lz used in the present study were not toxic to the preovulatory follicles and likely relevant as an experimental system. Therefore, to gain a better understanding of the mechanism of ovulation in this fish, we addressed the nature of the inhibitory effect of Lz on follicular ovulation. The results of the present study report a novel and indispensable role for melatonin in follicle rupture during ovulation in medaka.
These data indicated that in the medaka ovary, Aanat1a and Hiomt2 expression in the granulosa cells plays a role in producing melatonin in the preovulatory follicle. The expression levels of these enzymes were invariable in the follicle during the spawning cycle. These results are consistent with the fact that the follicular melatonin levels were fairly constant during spawning. In contrast, the serum melatonin levels remained low in the light and elevated in the dark. Previous studies have established that Aanat is a rate-limiting enzyme in the melatonin synthesis pathway, and the expression of this protein is transcriptionally regulated in the pineal gland of vertebrates [13] . Thus, a similar mechanism regulating the expression of Aanat1a might operate in the medaka pineal Commercially available antibodies were used. Positions of various molecular masses are indicated. Actb was used as a control. Dotted lines represent cropping of single gel. The reproducibility of the results was confirmed after repeating three times, and the results of one experiment are presented. Note that no band was detected using the Rdx B antibody. A very faint band visible at À5 and À3 h is considered to be nonspecific because it was also detected even using the absorbed primary antibody. B) Extracts of preovulatory follicles isolated at 7 h prior to ovulation were immunoprecipitated with an antibody against Msn A or normal mouse IgG. The resulting precipitated materials were analyzed through Western blots using antibodies for phosphorylated Erm (pErm) or Msn A. The reproducibility was confirmed after repeating the experiments three times, and the results of one experiment are presented. C) Preovulatory follicles isolated at 4 h prior to ovulation were incubated with Lz, GW627368X (GW), jasplakinolide (Jas), or cytochalasin B (CB). Follicles cultured without additives (0 h and 4 h) were also used as a control. After 4 h of incubation, the follicular layers of the follicles were collected, and the extracts were analyzed for pERM and Msn A. Dotted lines indicate cropped images from separate blots, and the samples were run under the same experimental conditions. D) Preovulatory follicles isolated at 4 h prior to ovulation were incubated with or without Lz. Follicles incubated without additives (0 h and 4 h) were also used as a control. After 4 h of incubation, the follicular layers of the follicles were subjected to G-actin (G) and F-actin (F) fractionation. The resulting fractions were analyzed through Western blots using antibodies for pErm and Msn A. Experiments were repeated three times to confirm the reproducibility of the results. E) Preovulatory follicles isolated at 4 h prior to ovulation were incubated with or without Lz. The follicular layers of the follicles were collected every 1 h, and Western blot analysis for pErm or Msn A was conducted using extracts prepared from the layers. The reproducibility was confirmed after repeating the experiments three times, and the results of one experiment are presented.
gland. Based on the data obtained in the present study, we assume the presence of a distinct mechanism for follicular melatonin synthesis in the fish. We also propose that the preovulatory follicle might be freed from the influence of elevated serum melatonin levels.
Notably, the aanat1a mRNA levels exhibited a dramatic increase within a few hours of ovulation, while the corresponding protein levels remained stable during the same period. The nature of the lack of consistency remains to be determined in the future.
Among the four medaka melatonin receptors, Mtnr1a-a acts as a signal transducer through the conversion of melatoninbinding events into intracellular signals in the granulosa cells of preovulatory follicles. In vitro experiments using medaka OLHNI-2 cells showed that FSK-stimulated cAMP formation was reduced when Mtnr1a-a was activated through melatonin. Previous studies have established that the inhibition of cAMP formation via the toxin-sensitive G protein is the best signaling pathway for melatonin receptors in mammalian tissues [2] . By analogy, medaka Mtnr1a-a might be coupled with the toxinsensitive G protein.
Our data indicate a lack of the Mtnr1c protein in spite of the presence of a large abundance of the corresponding mRNA in the ovary. A plausible explanation for this would be that translation of Mtnr1c mRNA is inhibited in the follicles of the fish ovary. Indeed, existing evidence reveals the translational inhibition of zebrafish cyclin B1 mRNA in the oocyte of the preovulatory follicle and that cyclin B1 translation begins after exposure of the oocyte to MIH (17,20bP) , which is rapidly generated in follicle cells by an LH surge [15] . In addition, we previously found that enteropeptidase mRNA, but not the corresponding protein, is expressed abundantly in the medaka ovary [28] . Therefore, we tentatively assume that, like cyclin B and enteropeptidase, the expression of Mtnr1c may be regulated not only at the transcriptional level but also at the translational level in the ovary of the fish. An alternative possibility is that mtnr1c mRNA might function as microRNA or noncoding RNA in the ovary.
The present study revealed two novel roles for melatonin in follicle ovulation: 1) melatonin contributes to constitutive cytosolic phospholipase A2 (Pla2g4a) expression in preovulatory follicles and 2) melatonin plays a role in Msn A phosphorylation in follicles with impending ovulation. Based on these data, we propose a model explaining the effects of melatonin on the preovulatory follicles that are destined to ovulate (Fig. 10) . As shown in Figure 1A , postvitellogenic follicles ovulate in 24 h in vivo. In the 24 h spawning cycle, the follicles undergo an LH surge at approximately 17-18 h before the expected time of ovulation [21] . From the time of the surge onward, the granulosa cells of the follicles start to synthesize a variety of proteins that are necessary for successful ovulation. Mmp15 (also known as MT2-MMP) [20, 21] , Pgr (nuclear progestin receptor) [25] , Ptger4b (PGE 2 receptor subtype EP4b) [25] , and Pai1 (plasminogen activator inhibitor-1) [26] are Lh-dependent and ovulation-related genes/proteins in medaka fish. In contrast to these proteins, the Mtnr1a-a receptor is expressed in the granulosa cell membrane of the follicles through the spawning cycle, irrespective of whether the follicles undergo the gonadotropin surge. The melatonin receptor could be activated through melatonin because the ligand is always available. Melatonin binding to the Mtnr1a-a receptor likely induces the constitutive expression of Pla2g4a, which releases arachidonic acid from membrane phospholipids. Arachidonic acid is subsequently converted into PGE 2 through the sequential action of cyclooxygenase-2 and PGE 2 synthase, both of which are also expressed in the granulosa cells of the follicle. Similar to melatonin, the PGE 2 levels in the fish preovulatory follicles are constant throughout the spawning cycle [22] . PGE 2 is highly unstable in vivo in mammals [38] . If this mechanism is also present in the teleost medaka, then the enzymes responsible for the synthesis of this compound should be active in these cells. We tentatively assume that the melatonin generated by the granulosa cells of the follicles could trigger the onset of a series of reactions initiated by Mtnr1a-a receptor activation. The contribution of the oocyte to the production of melatonin in the preovulatory follicle may be limited, as suggested by the present finding that Aanat1a and Hiomt2 were not expressed at detectable levels in the oocyte. However, we cannot rule out the possibility that pineal melatonin may also contribute to receptor activation.
Msn A is an Erm protein that acts as a major linker between the plasma membrane and actin cytoskeleton and is involved in cell shape changes, such as directed cell migration and cell polarity formation [39] . The present study revealed that Msn A is synthesized in an Lh-independent manner in the granulosa cells of the follicles at approximately 7 h prior to ovulation and 
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that the synthesis of this protein lasts until the time of ovulation. These data indicated that Msn A is phosphorylated immediately after synthesis. Because phosphorylated Erm proteins associate with F-actin at the C-terminal domain and membrane components at the N-terminal domain [39, 40] , the intracellular actin cytoskeleton (F-actin) might be immobilized to the cytoplasmic side of the cell membrane via phosphorylated Msn A. Currently, the membrane protein that interacts with Msn A in the follicles has not been identified. As shown in the present study, depolymerization of the actin cytoskeleton in granulosa cells is initiated at approximately 3 h prior to ovulation. Considering that phosphorylated Msn A is detectable at 7 h prior to ovulation, these facts suggest that intracellular actin depolymerization, and the accompanying ovulation, is delayed by several hours, even when the immobilization of the actin cytoskeleton to the membrane occurs soon after the production of phosphorylated Msn A.
We previously showed that the PGE 2 /Ptger4b system plays a role in fish follicle ovulation [22] . The critical timing of the PGE 2 /Ptger4b interaction was between À1 and 0 h of ovulation. These data demonstrated that the activation of the PGE 2 /Ptger4b system is required to drive actin depolymerization in the follicular cells during ovulation. Notably, in this context, the involvement of actin cytoskeleton rearrangement in the teleost ovulation was initially suggested almost 40 years ago [41] . In that study, the authors reported a substantial cytochalasin B-mediated inhibition of medaka in in vitro follicle ovulation, although the underlying mechanisms remained unsolved until recently. In the present study, the inhibitory effect of this compound on follicle ovulation was confirmed, and cytochalasin B treatment induced actin depolymerization in the granulosa cells of ovulating follicles. Similarly, normal follicle ovulation involves actin depolymerization in these cells, but the observed actin depolymerization in the granulosa cells of cytochalasin B-treated follicles occurred to an extreme extent. The G-actin:F-actin ratio in the follicle layer cells of untreated follicles at ovulation did not exceed a value of 5, whereas the ratio in the cytochalasin Btreated, unovulated follicles was as high as 20. We postulate that such an extraordinary intracellular actin depolymerization induced by cytochalasin B treatment probably caused a failure of follicle ovulation. Our data indicate the presence of a wellregulated mechanism governing both the extent and timing of actin cytoskeleton polymerization/depolymerization in follicular granulosa cells. The results of the present study also revealed that actin cytoskeleton reorganization accompanying ovulation is regulated through at least two receptor systems, melatonin/Mtnr1a-a and PGE 2 /Ptger4b. Additional insights into the mechanisms through which these receptor systems synchronously function to regulate actin cytoskeleton depolymerization in the granulosa cells of ovulating follicles requires further investigation.
The follicular melatonin levels and melatonin receptor expression levels are stable during ovulation. In support of this finding, the expression levels of Aanat1a, Hiomt2, and Mtnr1a-a are unaltered during the process, suggesting that LH or MIH is probably not involved in the constitutive expression of these proteins. We believe that melatonin is necessary for ovulation, but only at background levels. As we previously reported, Mmp2 (also known as gelatinase A) [20] , Mmp16 (MT1-MMP) [20] , Plau1 (urokinase-type plasminogen activator1) [26] , and Ptgs2 (Cox2) [22] are all stably expressed in the follicle during ovulation, but critical roles of the enzymes for ovulation were experimentally demonstrated. Like these enzymes, constitutive expression of Aanat1a, Hiomt2, and Mtnr1a-a in the preovulatory follicles is regulated by a mechanism different from that involving LH or MIH. However, currently, the molecular mechanisms for the follicular expression of Aanat1a, Hiomt2, and Mtnr1a-a are unknown.
Notably, previous studies of the effect of melatonin on ovulation have been conducted in mammalian species. Melatonin is produced in both granulosa cells and in the oocytes of ovarian follicles, and this compound is beneficial to neighboring cells. As a receptor-independent free radical scavenger and broad-spectrum antioxidant, melatonin reduces the accumulation of damaged oocytes [3, 11, 42] , thereby facilitating follicle survival and ensuring oocyte maturation and subsequent ovulation. Undoubtedly, evidence showing that melatonin is involved in PGE 2 synthesis and actin cytoskeleton rearrangement via Msn A phosphorylation during medaka ovulation suggest a novel role for melatonin in the reproductive organs of vertebrate species. In any case, the present study provides the first evidence clarifying the relationship between melatonin and PGE 2 during ovulation.
In summary, the results of the present study provided evidence for the role of melatonin in ovulation in vertebrates using medaka as a model system. These data demonstrated that the melatonin that is produced in the granulosa cells of preovulatory follicles plays a dual role in ovulation, specifically in the synthesis of PGE 2 and actin cytoskeleton reorganization, both of which are required for fish ovulation. To our knowledge, this study provided the first evidence in any species of the effects of melatonin on ovarian function from a mechanistic standpoint.
